Abdominal aortic aneurysms.
Natzi Sakalihasan, Jean-Baptiste Michel, Athanasios Katsargyris...
https://pubmed.ncbi.nlm.nih.gov/30337540Actively Recruiting
Age: 20Years - 90Years
All Genders
ID06775821
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
Led by First Affiliated Hospital of Kunming Medical University · Updated on 2025-01-15
2000
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
F
First Affiliated Hospital of Kunming Medical University
Lead Sponsor
T
The Third Affiliated Hospital of Kunming Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating the relationship between abdominal aortic aneurysm (AAA) and primary lung cancer. Recent studies suggest many lung cancer cases are detected alongside AAA, but the exact incidence and mechanisms remain unclear. This study aims to provide detailed epidemiological data to improve screening, treatment, and long-term survival for lung cancer patients who may also have AAA. The study collects detailed information from 2000 to 3000 outpatients diagnosed with primary lung cancer between October 2022 and April 2025. Data include basic demographics, lifestyle habits, medical and family history, and laboratory tests. Participants undergo ultrasound or CT scans of the abdominal aorta to check for AAA. Researchers will analyze risk factors and follow patients long-term to understand the connection between lung cancer and AAA. Participants provide information through interviews and medical record reviews at two hospitals. Follow-up includes monitoring lung cancer progression, AAA presence, treatment details, and patient outcomes. Researchers measure the incidence of AAA in lung cancer patients and conduct epidemiological analyses. The study runs until April 2025, aiming to improve screening and prevention strategies for AAA in lung cancer patients.
CONDITIONS
Brief Title
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
Who Can Participate
Age: 20Years - 90Years
All Genders
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with primary lung cancer through clinical or pathological examination
You will not qualify if you...
- Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - From October 2022 to April 2025
Participants undergo ultrasound or CT imaging of the abdominal aorta to detect the presence of abdominal aortic aneurysm.
1 to 2 visits depending on imaging schedule
Long-term Monitoring
Duration - Up to 2 years and 7 months
Participants provide detailed epidemiological data and undergo long-term follow-up to collect information on lung cancer and abdominal aortic aneurysm outcomes.
Periodic follow-up visits during the study period
Trial Site Locations
Total: 2 locations
1
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China, 650000
Actively Recruiting
2
The Third Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China, 650000
Actively Recruiting
Loading map...
Research Team
K
Kai-xiong Qing, Ph.D.
Q
Qian Zhu, MBBS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Management of Abdominal Aortic Aneurysms.
Andres Schanzer, Gustavo S Oderich
https://pubmed.ncbi.nlm.nih.gov/34706173Abdominal aortic aneurysm: update on pathogenesis and medical treatments.
Jonathan Golledge
https://pubmed.ncbi.nlm.nih.gov/30443031Prevalence of abdominal aortic aneurysms in patients with lung cancer.
Khaled I Alnahhal, Vanessa Urhiafe, Meyyammai Narayanan...
https://pubmed.ncbi.nlm.nih.gov/34634421High prevalence of abdominal aortic aneurysms in patients with lung cancer.
Brody Wiles, Matthew Comito, Nicos Labropoulos...
https://pubmed.ncbi.nlm.nih.gov/32623102Risk of various cancers in adults with abdominal aortic aneurysms.
Hyung-Jin Cho, Ju-Hwan Yoo, Mi-Hyeong Kim...
https://pubmed.ncbi.nlm.nih.gov/35850163Coprevalence and Incidence of Lung Cancer in Patients Screened for Abdominal Aortic Aneurysm.
Anna Hohneck, Tetyana Shchetynska-Marinova, Gerhard Ruemenapf...
https://pubmed.ncbi.nlm.nih.gov/32620663The incidence of pulmonary neoplasms discovered by serial computed tomography scanning after endovascular abdominal aortic aneurysm repair.
Nancy L Harthun, Christine L Lau
https://pubmed.ncbi.nlm.nih.gov/21129909[Why screen for lung cancer in patients with arterial disease?].
M Lederlin, J Trédaniel, P Priollet
https://pubmed.ncbi.nlm.nih.gov/262765622014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).
Raimund Erbel, Victor Aboyans, Catherine Boileau...
https://pubmed.ncbi.nlm.nih.gov/25173340